NCAM1 and Miyoshi myopathy: Within the group of MM patients, the CD56+/CD56++ ratio was lower compared to lymphoma patients, but it was only significantly lower at TP2 (1.656 vs. 0.6578; p-value: 0.0019; Figure 2D).